🔎 Trials Near Me

Nyumbani › Scleroderma › Illinois › Chicago

Majaribio ya kliniki ya Scleroderma katika Chicago, IL

Masomo 10 ya Scleroderma yanatafuta washiriki katika vituo vya Chicago na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

InaajiriHatua 3
  • Northwestern University, Chicago
  • The University of Chicago Medical Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Sep 2026 · NCT07497087

A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

InaajiriHatua 2
  • University of Illinois Health Outpatient Care Center, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06655155

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

InaajiriHatua 1
  • The University of Chicago Medical Center, Chicago
Umri 18 hadi 74 · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

InaajiriHatua 2/3
  • GSK Investigational Site, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

InaajiriHatua 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

InaajiriHatua 2
  • The University of Chicago Medical Center (UCMC), Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

InaajiriHatua 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

InaajiriHatua 1/2
  • Nkarta Investigational Site, Chicago
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 7 Ago 2026 · NCT06733935

A Study of AZD0120 in Autoimmune Diseases

InaajiriHatua 1
  • Research Site, Chicago
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 28 Jul 2026 · NCT07295847

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

InaajiriHatua 2
  • aTyr Investigative Site, Chicago
  • aTyr Investigative Site, Chicago
  • aTyr Investigative Site, Chicago
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2025 · NCT05892614

Majaribio ya Scleroderma katika miji mingine

Masomo mengine katika Chicago

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.